A Pilot Study of mDOT for Immunosuppressant Adherence in Adolescent Kidney Transplant Recipients
NCT03504137 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1
Last updated 2021-10-19
Summary
The investigators are interested in whether or not the use of a mobile health (mHealth) application increases the rate of immunosuppression medication adherence among adolescent kidney transplant recipients. The investigators aim to test this by recruiting adolescent (ages 14-21) kidney transplant recipients to use an mHealth application to record themselves taking their immunosuppression medications, and tracking medication adherence over time. The study population will be approximately 50 adolescent kidney transplant recipients at the Johns Hopkins Hospital.
Conditions
- Medication Adherence
- Kidney Transplant
Interventions
- OTHER
-
mHealth Intervention
The video DOT app will allow transplant recipients to see their medication regimen, record themselves taking every dose, report side effects or symptoms, visualize their treatment progress, access educational content, and track appointments. This information is encrypted and transmitted to a HIPAA-secure web portal for providers to review.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Macey L Henderson, JD PhD · Johns Hopkins University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 14 Years
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-04
- Primary Completion
- 2020-08-28
- Completion
- 2020-08-28
Countries
- United States
Study Locations
More Related Trials
-
Intervention to Improve Adherence in Teen Kidney Transplant
NCT01356277 ·Status: COMPLETED ·Phase: NA
-
Trial of Rituximab Given Pre-Transplant to Sensitised Live Donor Kidney Recipients
NCT00371904 ·Status: UNKNOWN ·Phase: PHASE2
-
Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients
NCT02426502 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver Transplant
NCT04104438 ·Status: COMPLETED ·Phase: PHASE4
-
Improving Medication Adherence in Adolescents Who Had a Liver Transplant
NCT03691220 ·Status: COMPLETED ·Phase: NA
-
Teen Adherence in KidnEy Transplant, Improving Tracking To Optimize Outcomes (Stage 1)
NCT02910661 ·Status: COMPLETED
-
Safety and Efficacy Study of Rituximab in Renal Transplantation
NCT00255593 ·Status: COMPLETED ·Phase: PHASE1
-
Myfortic vs. Cellcept in Kidney Transplant Recipients
NCT00533624 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Tolerance by Engaging Antigen During Cellular Homeostasis
NCT03504241 ·Status: COMPLETED ·Phase: PHASE1
-
Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant
NCT00167791 ·Status: WITHDRAWN ·Phase: NA
-
Medication Adherence in Children Who Had a Liver Transplant
NCT01154075 ·Status: COMPLETED
-
Effects of Inhibiting Early Inflammation in Kidney Transplant Patients
NCT02495077 ·Status: COMPLETED ·Phase: PHASE2
-
Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients
NCT00183248 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids
NCT01304836 ·Status: COMPLETED ·Phase: PHASE4
-
Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
NCT05525507 ·Status: RECRUITING ·Phase: PHASE1
-
ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients
NCT01905514 ·Status: UNKNOWN ·Phase: NA
-
A Study To Test An Anti-Rejection Therapy After Kidney Transplantation
NCT00000936 ·Status: TERMINATED ·Phase: PHASE3
-
Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients
NCT00522548 ·Status: TERMINATED ·Phase: PHASE4
-
Bortezomib in Rejection of Kidney Transplants
NCT02201576 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch
NCT00275509 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients
NCT01336296 ·Status: COMPLETED ·Phase: PHASE4
-
Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk
NCT04473924 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients
NCT03221842 ·Status: TERMINATED ·Phase: PHASE3
-
Iguratimod in Kidney Transplant Recipients
NCT02839941 ·Status: UNKNOWN ·Phase: NA
-
A Study of Mycophenolate Mofetil and Cyclosporin, Without Concomitant Corticosteroids, After a First Renal Transplant
NCT00200551 ·Status: COMPLETED ·Phase: PHASE4